Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Magnetic Resonance Spectroscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 163 Breast Neoplasms 123 Lung Neoplasms 99 Carcinoma, Non-Small-Cell Lung 82 Glioblastoma 76 Brain Neoplasms 74 Neoplasm Metastasis 67 Glioma 67 Pancreatic Neoplasms 49 Neoplasms 44 Multiple Myeloma 44 Carcinoma, Renal Cell 44 Colorectal Neoplasms 42 Squamous Cell Carcinoma of Head and Neck 38 Lymphoma, Large B-Cell, Diffuse 38 Carcinoma, Hepatocellular 36 Ovarian Neoplasms 34 Melanoma 33 Lymphoma 33 Urinary Bladder Neoplasms 32 Astrocytoma 29 Sarcoma 26 Rectal Neoplasms 25 Oropharyngeal Neoplasms 24 Lymphoma, Follicular 24 Central Nervous System Neoplasms 24 Uterine Cervical Neoplasms 23 Triple Negative Breast Neoplasms 22 Lymphoma, Non-Hodgkin 22 Gliosarcoma 22

Interventions

Hyperthermic Intraperitoneal Chemotherapy 28 Paclitaxel 24 Cisplatin 23 Oxaliplatin 18 Cytoreduction Surgical Procedures 17 Carboplatin 17 Fluorouracil 14 Bevacizumab 10 Mitomycin 9 Leucovorin 9 Doxorubicin 9 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Laparoscopy 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07001748 2026-03-23

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡